Year Established :
1950
Total Assets(USD) :
50,000,000 To 54,999,999
Total Number of Staff :
more than 500
Business Type :
Manufacturer,Trading Company,Trading Company
Annual Turnover(USD) :
50,000,000 To 54,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Excipients,Natural Extracts,Finished Dosage
Product Range :
*****DOMINANT PRODUCTS LISTS*******
PHARMACEUTICAL EXCIPIENTS,
1. Sodium Starch Glycolate (USDMF, USP)
2. Pregelatinized Starch (USP)
3. Low Substitute-Hydroxpropyl Cellulose (USP)
4. Hydroxypropyl Methyl Cellulose (USP)
5. Microcry Stalline Cellulose (USP)
6. Methyl Cellulose (USP)
7. Ethyl Cellulose (USP)
8. Premixed Adjuvant as Medical Coating
9. Polyacrylic ResinⅡ(L-100, USP)
10. Polyacrylic ResinⅢ(S-100, USP)
11. Polyacrylic ResinⅣ(E-100, USP)
12. Povidone K30 (USP,EP,BP)
13. Calcium Sulfate (CP,)
14. Magnesium Stearate (BP)
15. Stearic Acid (CP)
16. Silicon Dioxide (CP, Food Grade)
17. Soluble Starch (CP,Food Grade)
18. Calcium Hydrogen Phosphate (CP)
API:
1. Methotrexate (USDMF/COS/JPDMF)
2. Calcium Folinate (COS)
3. Esmolol Hydrochloride (USDMF/COS)
4. Milrone (USDMF)
5. Amrinone (USDMF)
6. Etomidate (Pending,USP)
7. Pemetrexed Disodium (New Product, USP)
8. Azacytidine (New Product, EP)
Other excipients and API, Intermediates and Nutritions which pharma may concern.
Seven years of qualification
Audited Supplier
Pharma Sources Insight July 2025
